186 related articles for article (PubMed ID: 22994157)
1. Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?
Puiggros A; Puigdecanet E; Salido M; Ferrer A; Abella E; Gimeno E; Nonell L; Herranz MJ; Galván AB; Rodríguez-Rivera M; Melero C; Pairet S; Bellosillo B; Serrano S; Florensa L; Solé F; Espinet B
Leuk Lymphoma; 2013 May; 54(5):986-95. PubMed ID: 22994157
[TBL] [Abstract][Full Text] [Related]
2. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
[TBL] [Abstract][Full Text] [Related]
3. Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia.
O'Malley DP; Giudice C; Chang AS; Chang D; Barry TS; Hibbard MK; Chen R; Chen ST
Int J Lab Hematol; 2011 Jun; 33(3):238-44. PubMed ID: 21143592
[TBL] [Abstract][Full Text] [Related]
4. Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panel.
Urbankova H; Papajik T; Plachy R; Holzerova M; Balcarkova J; Divoka M; Prochazka V; Pikalova Z; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):56-64. PubMed ID: 23073527
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
Vetro C; Haferlach T; Jeromin S; Stengel A; Zenger M; Nadarajah N; Baer C; Weissmann S; Kern W; Meggendorfer M; Haferlach C
Br J Haematol; 2018 Oct; 183(1):47-59. PubMed ID: 30022491
[TBL] [Abstract][Full Text] [Related]
6. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
[TBL] [Abstract][Full Text] [Related]
7. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
[TBL] [Abstract][Full Text] [Related]
9. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.
Glassman AB; Hayes KJ
Cancer Genet Cytogenet; 2005 Apr; 158(1):88-91. PubMed ID: 15771912
[TBL] [Abstract][Full Text] [Related]
10. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
11. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
[TBL] [Abstract][Full Text] [Related]
12. FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.
Dubuc AM; Davids MS; Pulluqi M; Pulluqi O; Hoang K; Hernandez-Sánchez JM; Schlich C; Hernández-Rivas JM; Brown JR; Dal Cin P
Am J Hematol; 2016 Oct; 91(10):978-83. PubMed ID: 27341486
[TBL] [Abstract][Full Text] [Related]
13. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
14. [Detection of genomic abnormalities among 105 patients with chronic lymphocytic leukemia using fluorescence in situ hybridization].
Wang H; Xu H; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):357-360. PubMed ID: 28604954
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia.
Higgins RA; Gunn SR; Robetorye RS
Mol Diagn Ther; 2008; 12(5):271-80. PubMed ID: 18803425
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
17. Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go.
Puiggros A; Blanco G; Espinet B
Biomed Res Int; 2014; 2014():435983. PubMed ID: 24967369
[TBL] [Abstract][Full Text] [Related]
18. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.
Patel A; Kang SH; Lennon PA; Li YF; Rao PN; Abruzzo L; Shaw C; Chinault AC; Cheung SW
Am J Hematol; 2008 Jul; 83(7):540-6. PubMed ID: 18161787
[TBL] [Abstract][Full Text] [Related]
19. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
Dos Santos P; Panero J; Palau Nagore V; Stanganelli C; Bezares RF; Slavutsky I
Tumour Biol; 2015 Nov; 36(11):8317-24. PubMed ID: 26008147
[TBL] [Abstract][Full Text] [Related]
20. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
Wawrzyniak E; Kotkowska A; Blonski JZ; Siemieniuk-Rys M; Ziolkowska E; Giannopoulos K; Robak T; Korycka-Wolowiec A
Eur J Haematol; 2014 Feb; 92(2):91-101. PubMed ID: 24138550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
